Article Per Year (5 Year)
p-Index From 2021 - 2026
4.53
P-Index
This Author published in this journals
All Journal Jurnal Ilmiah Farmasi Dinamisia: Jurnal Pengabdian Kepada Masyarakat JSFK (Jurnal Sains Farmasi & Klinis) Jurnal Ilmu Kefarmasian Indonesia Pharmacoscript Jurnal Farmamedika (Pharmamedica Journal) Journal of Holistic and Health Sciences (Jurnal Ilmu Holistik dan Kesehatan) Journal of Experimental and Clinical Pharmacy (JECP) Jurnal IPTEK Bagi Masyarakat Jurnal Pengabdian Masyarakat Aufa (JPMA) Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Jurnal Ilmiah Bakti Farmasi Medical Sains : Jurnal Ilmiah Kefarmasian Jurnal Farmasi Sains dan Praktis Sciences of Pharmacy Jurnal Pengabdian Pada Masyarakat Jurnal Farmasi Indonesia Jurnal Ilmiah Kesehatan Delima Borneo Journal of Pharmacy Medical Sains : Jurnal Ilmiah Kefarmasian Jurnal Farmasi Galenika
Baha Udin
Program Studi S1 Farmasi, Sekolah Tinggi Ilmu Kesehatan Salsabila Serang
Religion Aerospace Engineering Agriculture, Biological Sciences & Forestry Arts Humanities Astronomy Automotive Engineering Biochemistry, Genetics & Molecular Biology Chemical Engineering, Chemistry & Bioengineering Chemistry Civil Engineering, Building, Construction & Architecture Computer Science & IT Control & Systems Engineering Decision Sciences, Operations Research & Management Dentistry Earth & Planetary Sciences Economics, Econometrics & Finance Education Electrical & Electronics Engineering Energy Engineering Environmental Science Health Professions Immunology & microbiology Industrial & Manufacturing Engineering Languange, Linguistic, Communication & Media Law, Crime, Criminology & Criminal Justice Library & Information Science Materials Science & Nanotechnology Mathematics Mechanical Engineering Medicine & Pharmacology Neuroscience Nursing Physics Public Health Social Sciences Transportation Veterinary Other

Published : 30 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 30 Documents
Search

 1   2   3 
The Effect of Directly Observed Treatment Strategy on Cost Utility of Pulmonary Tuberculosis Patients at Banten Regional Public Hospital Udin, Baha; Yusransyah, Yusransyah; Saepudin, Saepudin
Borneo Journal of Pharmacy Vol. 8 No. 1 (2025): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v8i1.8601

Abstract

Pulmonary tuberculosis (TB) is one of the communicable diseases with high prevalence in some provinces in Indonesia, including the Province of Banten. Considering its high prevalence and the high cost of treatment resulting from multiple treatment components, research on the analysis of treatment costs of TB is very important. This study aimed to determine the effect of implementing the directly observed treatment (DOT) strategy on the cost-utility of pulmonary TB patients. The study was conducted at Banten Regional General Hospital using the perspective of the health provider and patients by involving 24 TB patients. Treatment cost was calculated by including direct medical costs, direct non-medical costs, and indirect costs, and then categorized into initial and final cost-utility. The average cost-effectiveness ratio (ACER) was then calculated by setting the patient's quality of life as the clinical outcome in this study. This study found that the average value of the average cost-utility ratio (ACUR) for the initial cost-utility and the final cost-utility were IDR 2,682,343.53 and IDR 2,402,153.15, respectively, and the difference was statistically significant (p=0.006). It indicates that the DOT strategy can potentially improve the utility costs of the treatment of TB patients at Banten Regional Hospital.
EVALUASI IMPLEMENTASI PELAYANAN KEFARMASIAN PADA PUSKESMAS DI KABUPATEN PANDEGLANG TAHUN 2024 Yusransyah, Yusransyah; Stiani, Sofi Nurmay; Nasiti, Febriane Dwi; Kelutur, Faruk Jayanto; Udin, Baha
Jurnal Ilmiah Ibnu Sina (JIIS): Ilmu Farmasi dan Kesehatan Vol 10 No 1 (2025): Jurnal Ilmiah Ibnu Sina
Publisher : Sekolah Tinggi Ilmu Kesehatan ISFI Banjarmasin

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36387/jiis.v10i1.2389

Abstract

Pharmaceutical services are considered by some observers to be below standard. Both pharmacists and pharmaceutical technicians as health technicians are required to improve their skills, knowledge and behavior in order to provide quality direct services to patients. The purpose of this study was to determine the implementation of pharmaceutical services at Health Centers in Pandeglang Regency in 2023. This study is an observational study with a case study design. The method used is descriptive using checklist sheets and open statements. Based on the results of this study, there are significant differences in the aspects of facilities and infrastructure and clinical pharmacy services and there are differences but not significant in the aspects of managing pharmaceutical preparations and disposable medical materials. The conclusion of this study is that pharmaceutical services at Health Centers in Pandeglang Regency are in accordance with Permenkes No. 74 of 2016 by obtaining a percentage value of 79%, entering the GOOD category.
ANALISIS EFEKTIVITAS BIAYA PASIEN COVID-19 MENGGUNAKAN TERAPI OKSIGEN DAN REMDESIVIR DI RSUD KABUPATEN TANGERANG Yusransyah, Yusransyah; Udin, Baha; Abdillah , Mursyid; Murdianto, Yudi; Soraya Uli, Elisabeth; Suryana, Nana
JFIOnline | Print ISSN 1412-1107 | e-ISSN 2355-696X Vol 14 No 1 (2022): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (419.714 KB) | DOI: 10.35617/jfionline.v14i1.75

Abstract

COVID-19 is a contagious disease, so there is a potential for an increase in the number of COVID-19 cases. If there is an increase in incidence or prevalence, it will cause problems related to the costs and outcomes of an intervention. Therefore, a cost-effectiveness analysis is needed. This study aims to determine the cost-effectiveness of COVID-19 patients who use oxygen therapy with and without being given remdesivir. This study uses a cost-effectiveness analysis method that takes into account the ACER (Average Cost-Effectiveness Ratio) and ICER (Incremental Cost-Effectiveness Ratio) values. The data used is retrospective data and sampling is done by purposive sampling, the sample obtained in this study amounted to 34 cases. The results of this study showed that the total average direct medical costs of the remdesivir group were Rp. 32,399,532 with an effectiveness of 47%, while in the non-remdesivir group the total average direct medical costs were Rp. 26,853,729 with an effectiveness of 41%. The ACER value obtained in this study was Rp. 688,490 in the remdesivir group and Rp. 654,969 in the non-remdesivir group. The results of the ICER calculation in this study were Rp. 924,301 per day of hospitalization. In this study, it can be concluded that the therapy group of COVID-19 patients who use oxygen therapy without being given remdesivir is more cost-effective than the therapy group of COVID-19 patients who use oxygen therapy with remdesivir.
Cost-Effectiveness of Oseltamivir and Favipiravir in Covid-19 Patients: a Cost-Effectiveness Analysis Study in a Hospital Yusransyah, Yusransyah; S.farm, Baha Udin
JSFK (Jurnal Sains Farmasi & Klinis) Vol 12 No 1 (2025): J Sains Farm Klin 12(1), April 2025
Publisher : Fakultas Farmasi Universitas Andalas

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.25077/jsfk.12.1.29-35.2025

Abstract

The COVID-19 pandemic poses not only a threat to health but also to the global economy, including healthcare costs. Although there is no specific drug for COVID-19 patients, there are antiviral drugs such as oseltamivir and favipiravir that can be used to treat COVID-19. The purpose of this study was to determine the most cost-effective antiviral therapy between oseltamivir and favipiravir for COVID-19 patients in one of the hospitals in Banten province. The pharmacoeconomic method used in this study was cost-effectiveness analysis by calculating the Average Cost-Effectiveness Ratio (ACER) and Incremental Cost-Effectiveness Ratio (ICER). The results of this study showed that the ACER value of the favipiravir group (IDR  364,010 (n = 7)) was lower than the oseltamivir group (IDR 431,744 (n = 7)), with an ICER value of IDR  60,605. Based on the results of the Mann-Whitney test, there was no significant difference between the costs of the favipiravir and oseltamivir groups (p value 0.940). The sensitivity test showed that the cost of medical consumables was the cost that had the greatest impact on cost-effectiveness. Based on the calculation results, it can be concluded that the favipiravir group is more cost-effective than the oseltamivir group.
Pharmacoeconomic Analysis of Drugs Used in Chronic Outpatients at Berkah Pandeglang Regional Hospital Yusransyah, Yusransyah; Nurhikmah, Ihda; Maharani, Zahra Citra; Stiani, Sofi Nurmay; Shobah, Afifah Nur; Udin, Baha
Sciences of Pharmacy Volume 4 Issue 3
Publisher : ETFLIN

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58920/sciphar0403343

Abstract

Hypertension and type 2 diabetes mellitus (T2DM) are chronic conditions requiring long-term pharmacotherapy, placing significant financial pressure on patients and healthcare systems. Drug selection should prioritize both clinical efficacy and cost-efficiency, particularly in resource-limited settings. This study conducted a pharmacoeconomic evaluation of commonly used therapies at RSUD Berkah Pandeglang using a retrospective, non-experimental design. Data were collected from 2023 outpatient records and analyzed from the hospital’s perspective. Cost-effectiveness was assessed using the Average Cost-Effectiveness Ratio (ACER). For hypertension, amlodipine (n = 20) had a lower ACER (Rp 283,913) than candesartan (n = 15; Rp 883,000), indicating higher cost-effectiveness. In T2DM patients, metformin (n = 25) was more cost-effective (ACER: Rp 317,746.75) than glimepiride (n = 25; ACER: Rp 607,148.84). These findings support prioritizing amlodipine and metformin as first-line treatments in similar public healthcare settings to improve therapeutic outcomes while managing costs.
Analisis biaya penggunaan analgetik sebagai terapi antinyeri pada pasien pasca bedah apendisitis di RSUD Aulia Pandeglang Yusransyah, Yusransyah; Stiani, Sofi Nurmay; Cahya, Wulan; Udin, Baha
Journal of Holistic and Health Sciences (Jurnal Ilmu Holistik dan Kesehatan) Vol. 9 No. 1 (2025): Journal of Holistic and Health Sciences (Jurnal Ilmu Holistik dan Kesehatan)
Publisher : Sekolah Tinggi Ilmu Kesehatan Holistik

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51873/jhhs.v9i1.349

Abstract

Latar belakang: Penggunaan analgetik sebagai terapi antinyeri pada pasien pasca bedah apendisitis di rumah sakit memiliki peran yang signifikan dalam mendukung proses pemulihan pasien. Namun, seiring meningkatnya biaya perawatan kesehatan, penting bagi fasilitas kesehatan untuk mengoptimalkan penggunaan analgetik agar tetap efektif namun juga ekonomis. Minimisasi biaya penggunaan analgetik tanpa mengorbankan efektivitas terapi menjadi tantangan utama dalam memastikan pasien mendapatkan perawatan yang optimal. Tujuan penelitian: Penelitian ini bertujuan untuk menentukan penggunaan obat analgesik dengan biaya paling rendah pada pasien pasca operasi apendisitis di RSUD Aulia Pandeglang. Metode penelitian: Metode penelitian yang digunakan adalah pengambilan data secara retrospektif dengan menggunakan data sekunder berupa rekam medis dan rincian biaya pengobatan pasien pasca operasi apendisitis yang tersedia di rumah sakit. Hasil: Hasil penelitian menunjukkan bahwa rata-rata biaya total untuk analgetik Tramadol injeksi dengan lama pengobatan 3 hari adalah Rp. 2.893.400,00/pasien, Dexketoprofen oral dengan lama pengobatan 3 hari adalah Rp. 11.051.400,00/pasien, Ketorolac injeksi dengan lama pengobatan 9 hari adalah Rp. 27.067.531,00/pasien, Paracetamol oral dengan lama pengobatan 7 hari adalah Rp. 13.212.000,00/pasien, Asam Mefenamat oral dengan lama pengobatan 10 hari adalah Rp. 2.929.000,00/pasien, Natrium Diklofenak oral dengan lama pengobatan 3 hari adalah Rp. 10.929.052,00/pasien, Ibuprofen oral dengan lama pengobatan 5 hari adalah Rp. 3.957.000,00/pasien, dan Ketoprofen injeksi dengan lama pengobatan 6 hari adalah Rp. 13.239.000,00/pasien. Simpulan: Berdasarkan data tersebut, analgetik injeksi Tramadol memiliki biaya total rata-rata paling rendah dibandingkan dengan analgetik lainnya
Mercury Identification Training and Safe Cosmetics Education for Babunnajah Vocational School Students.: Pelatihan Identifikasi Merkuri dan Edukasi Kosmetik Aman bagi Siswa SMK Babunnajah Stiani, Sofi Nurmay; Oktaviana Hadi, Agriyaningsih; Yusransyah, Yusransyah; Subchan, Mohamad; Nurul Fitri, Nabila; Septina Sumantri, Aulia; Udin, Baha
Dinamisia : Jurnal Pengabdian Kepada Masyarakat Vol. 9 No. 4 (2025): Dinamisia: Jurnal Pengabdian Kepada Masyarakat
Publisher : Universitas Lancang Kuning

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.31849/qtrzgt54

Abstract

The use of unsafe cosmetics among adolescents, particularly those containing mercury, remains a significant public health concern. This community service program aimed to enhance students’ knowledge at SMK Babunnajah through training in mercury identification and education on the safe use of cosmetics. The activity employed interactive lectures, group discussions, and hands-on mercury testing using simple reagent kits. An evaluation was conducted using pre-test and post-test questionnaires with 40 students. The results showed a substantial improvement in knowledge levels, with 70% of participants categorised as having high knowledge before the training, increasing to 100% afterwards. All knowledge indicators showed improvement, particularly in understanding product legality and the risks of mercury exposure. This training proved effective in fostering critical awareness and selective behaviour regarding cosmetic use. The program is recommended for replication in other vocational schools as a preventive measure against the use of illegal and harmful cosmetic products.
COST-EFFECTIVENESS DEXKETOPROFEN VS KETOROLAC IN CAESAREAN PATIENTS AT 'X' HOSPITAL, PANDEGLANG Yusransyah, Yusransyah; Sofi Nurmay, Stiani; Farahdina, Chairani; Latifah Nur, Rizki; Baha, Udin
Pharmacoscript Vol. 8 No. 2 (2025): Pharmacoscript
Publisher : Lembaga Penelitian dan Pengabdian Masyarakat, Universitas Perjuangan Tasikmalaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36423/pharmacoscript.v8i2.2150

Abstract

Post-cesarean section pain must be treated promptly and appropriately to prevent chronic conditions. Dexketoprofen and Ketorolac are non-narcotic analgesics commonly used to manage such pain. This study aimed to analyse the cost-effectiveness of dexketoprofen and ketorolac in patients undergoing cesarean sections at Mother and Child Hospital "X" in Pandeglang. The study used a cross-sectional design with cost-effectiveness analysis, specifically the Average Cost-Effectiveness Ratio (ACER). Pain intensity was measured one hour after surgery using the Faces Pain Rating Scale and Visual Analog Scale (VAS). Inclusion criteria were patients who underwent cesarean section and received non-narcotic analgesics. A total of 90 patients participated: 39 in the dexketoprofen group and 51 in the ketorolac group. Data were analyzed using ACER and the Mann-Whitney test. The ACER, based on the Faces Pain Rating Scale, showed a cost of IDR 1,142 for the dexketoprofen group and IDR 958.03 for the ketorolac group. Using the VAS, the cost was IDR 1,110 for dexketoprofen and IDR 657.45 for ketorolac. Statistical results showed a p-value < 0.05 for both pain measurement tools, indicating a significant difference in effectiveness between the two therapies. Based on both instruments, ketorolac was more cost-effective than dexketoprofen in managing post-cesarean section pain. This finding suggests that ketorolac may be a preferable option in clinical settings where cost and effectiveness are key considerations for post-operative analgesia in cesarean section patients.
Edukasi Masyarakat Mengenai Ketepatan Pilihan Kosmetik Melalui Aplikasi BPOM Stiani, Sofi Nurmay; Yusransyah, Yusransyah; Udin, Baha; Harpan, Andri; Salsabillah, Audy Nursifa'atun; Wibirezkina, Aufalya; Aulia, Ayu; Anwar, Ade; Endah, Endah
Jurnal Pengabdian Pada Masyarakat Vol 10 No 3 (2025): Jurnal Pengabdian Pada Masyarakat
Publisher : Universitas Mathla'ul Anwar Banten

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30653/jppm.v10i3.1401

Abstract

Kosmetik sering digunakan oleh masyarakat Indonesia untuk memperindah tubuh, tetapi berpotensi beredar produk ilegal dan berbahaya. Tujuan kegiatan ini, yaitu memberikan edukasi kepada masyarakat tentang pemilihan kosmetik yang tepat dan penggunaan aplikasi BPOM. Kegiatan dilakukan dalam tiga tahap (perencanaan, pelaksanaan, evaluasi) kepada 20 peserta di Kampung Jagabaya. Peserta seluruhnya perempuan, mayoritas berusia 19-44 tahun dengan pendidikan SD/MI. Peningkatan pengetahuan signifikan dari rata-rata skor pre-test 28 menjadi post-test 74,7 (p=0,001). Edukasi meningkatkan pengetahuan masyarakat terkait kosmetik dan penggunaan aplikasi BPOM. Cosmetics are frequently used by Indonesians to enhance their bodies, but they have the potential to contain illegal and dangerous products. The purpose of this activity is to educate the public about choosing the right cosmetics and using the BPOM application. The activity was carried out in three stages (planning, implementation, evaluation) with 20 participants in Jagabaya Village. All participants were female, the majority aged 19-44 years with elementary school education. There was a significant increase in knowledge from an average pre-test score of 28 to a post-test score of 74.7 (p=0.001). Education increased public knowledge regarding cosmetics and the use of the BPOM application.
Comparative Analysis of Cost Effectiveness of Ceftriaxone and Cefotaxime Antibiotic Therapy in Inpatients with Typhoid Fever in Aulia Pandeglang Regional Hospital in 2023 Yusransyah, Yusransyah; Rustiyani, Risa; Nurani, Agnes Wieanita; Stiani, Sofi Nurmay; Udin, Baha; Halimatusyadiah, Leni
Journal of Experimental and Clinical Pharmacy (JECP) Vol 5, No 2 (2025): August 2025
Publisher : Poltekkes Kemenkes Gorontalo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52365/jecp.v5i2.1436

Abstract

Typhoid fever is still a significant health problem for children in developing countries, including Indonesia. This disease is caused by infection with Salmonella Typhi bacteria, which is a Gram-negative bacteria and requires treatment with antibiotics. The use of antibiotics usually takes up a large portion of the hospital treatment budget. This study aims to compare the cost-effectiveness between two types of antibiotics, namely ceftriaxone and cefotaxime, in typhoid fever patients at Aulia Pandeglang Hospital, and to find the most cost-efficient treatment. This study is descriptive and observational, with retrospective data collection. The data used came from medical records and cost records of inpatients with typhoid fever in children aged 1 to 11 years at Aulia Pandeglang Hospital in 2023. A total of 20 patients met the study criteria. The outcomes measured in this study were the average length of stay in the hospital. The cost components calculated consisted of direct medical costs, such as drug costs, action costs, inpatient costs, medical device costs, and laboratory fees. The analysis was conducted from the payer's perspective. The results showed that the cost for the effectiveness of using ceftriaxone and cefotaxime was IDR 15,264 and IDR 18,265, with an ICER of IDR 257.9 to increase the effectiveness of cefotaxime. The conclusion of this study is that ceftriaxone is a more cost-effective antibiotic.
Co-Authors Abdillah , Mursyid Abdillah Mursyid Ade Anwar Adini, Syilvi Ai Yeni Herlinawati Anita Nugraheni, Diesty Asep Salman Alfarizqi Ashari, Elva Febri Aulia, Ayu Cahya, Wulan Candra Junaedi Chairani, Farahdina Deya Adiby Nabillah Diesty Anita Nugraheni Endah Endah endah, endah Endang Safitri Eneng Elda Ernawati Eneng Elda Ernawati Eva Kholifah Eva Kholifah Fajrin Noviyanto Fajrin Noviyanto, Fajrin Farahdina Chairani Farahdina, Chairani Fauzi, Andrian Maulana Fauzy, Adrian Maulana Ferdiyansyah, Ferdiyansyah Fifih Lutfiyah Fifih Lutfiyah Harpan, Andri Hasanah, Indah Ayu Nur Herawati, Fera Ismiyati, Renditya Kelutur, Faruk Jayanto Kholifah, Eva Kurnia, Nia Marlina Latifah Nur, Rizki Leni Halimatusyadiah Maharani, Sylvianti Maharani, Zahra Citra Muhamad Ichsan Fahlevy Murdianto, Yudi Nana Suryana Nasiti, Febriane Dwi Nurani, Agnes Wieanita Nurhikmah, Ihda Nurul Fitri, Nabila Ofsah, Olin Najilah Oktaviana Hadi, Agriyaningsih Perdi, Perdi Pratiwi, Linda Rani Pratiwi, Rossi Putri, Nabila Septiani Renditya Ismiyati Ristiani, Yuanisa Rizkiana, Muhammad Dinta Rozwaliza Annintan Rustiyani, Risa Saepudin Saepudin Salsabillah, Audy Nursifa'atun Selviani, Astri Septina Sumantri, Aulia Shobah, Afifah Nur Siti Rhopi’ah Sofi Nurmay Stiani Soraya Uli, Elisabeth Stiani, Sofi Nurmay Subchan, Mohamad Sumarlin US Teguh Sudarto US, Sumarlin Wibirezkina, Aufalya Yulistina, Isti Yuni Rahmawati Yusransyah, Yusransyah